OR WAIT null SECS
© 2022 MJH Life Sciences and BioPharm International. All rights reserved.
© 2022 MJH Life Sciences™ and BioPharm International. All rights reserved.
When considering whether to outsource work to a CRO, there are a number of factors to assess, including the type of work that may be outsourced, regulatory considerations, and needs for the study.
CDMOs offer expertise and customization options for sponsors of orphan drugs.
Demand for outsourced services of technical R&D activities is increasing.
June 01, 2022
Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, discusses the basics for maintaining an acceptable working relationship between a client and their CDMO.
May 31, 2022
Through the Thermo Fisher Scientific and LabShares Newton partnership, life science startups can accelerate early-stage discovery and development with shared lab spaces.
PerkinElmer has expanded its genomics testing services with the launch of its ultrarapid whole genome sequencing.
May 26, 2022
Lonza and Israel Biotech Fund form a two-year agreement to support accelerated development and manufacture of biologics and small molecules.
May 19, 2022
May 16, 2022
To build trust and ensure a high-quality product, companies must be sure their contracts are firm and their lines of communication even firmer.
May 15, 2022
CDMOs need to consistently demonstrate agility as demand increases for newly developed therapeutic modalities.
Acquisitions in the CDMO space can give us insight into a company's vision for their future.